Fasinumab (Anti-Human NGF), a human IgG1kappa monoclonal antibody targeting nerve growth factor (NGF), has applications in clinical studies for acute sciatica and knee osteoarthritis (OA) [1].
CAS Number:
[1190239-42-9]
* VAT and and shipping costs not included. Errors and price changes excepted